サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427765

便秘治療の世界市場レポート 2024

Constipation Treatment Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
便秘治療の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

便秘治療の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.7%の年間複合成長率（CAGR）で150億9,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、いくつかの重要な要因に起因する可能性があります。これらには、世界のヘルスケア支出の増加、予防ヘルスケア対策の重視の高まり、小児便秘の懸念への対処への注目の高まり、個別化されたヘルスケアソリューションへの需要の高まり、遠隔医療サービスの台頭、世界各国でのeコマースプラットフォームの拡大などが含まれます。ヘルスケア部門、消化器の健康のための機能性食品とプロバイオティクスへの注目に値する関心。この期間に予想される主な動向には、人工知能と機械学習の統合を含むヘルスケア技術の進歩、持続可能性の重視と環境に優しいヘルスケア製品の製造、革新的なソリューションを目指したヘルスケアプロバイダーとテクノロジー企業間の協力、便秘治療とヘルスケアソリューションの発展を目指した製薬企業による研究開発投資の増加が含まれます。

ファストフードの消費量の増加傾向が便秘治療市場の成長を促進すると予想されます。素早い準備と提供が特徴のファストフードは、繊維が不足していることが多く、脂肪や塩分が多く含まれる傾向があり、便秘関連の問題の原因となります。米国に本拠を置く紙およびプラスチック製品のプロバイダーであるバジェットブランダーズが2023年 8月に報告したように、ファストフード産業の世界市場価値は2027年までに9,317億米ドルに達すると予測されています。消費者は年間2,000億米ドルという驚異的な金額をファストフードに費やしています。このファストフード消費の急増は、便秘治療ソリューションの必要性が高まっていることを明確に示しています。

胃腸障害の発生率の増加により、便秘治療市場の成長が促進される見込みです。消化管に影響を与えるさまざまな症状を含む胃腸障害は、一般的な症状として便秘を示すことがよくあります。 便秘治療市場は、過敏性腸症候群（IBS）や炎症性腸疾患（IBD）などの胃腸疾患の有病率の上昇から恩恵を受ける立場にあります。英国に本拠を置く学術誌バイオメッド・セントラルによる2021年5月の報告書は、2035年までに炎症性腸疾患（IBD）の有病率が大幅に増加すると予想されることを強調しています。イラン、北アフリカ、中東、インド、東アジア、高地などの地域では、アジア太平洋地域および東南アジアでは、程度の差こそあれ、IBD症例が増加すると予想されます。この胃腸障害の有病率の増加は、効果的な便秘治療オプションに対する需要を強調し、市場の成長軌道を強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の便秘治療市場、治療タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 下剤
  • 塩化物チャネル活性化剤
  • 末梢作用性Mu-オピオイド受容体拮抗薬
  • GC-C（グアニル酸シクラーゼ-C）アゴニスト
  • その他の治療
  • 世界の便秘治療市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 慢性特発性便秘（CIC）
  • 便秘を伴う過敏性腸症候群（IBS-C）
  • オピオイド誘発性便秘（OIC）
  • 世界の便秘治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 地域および国の分析

  • 世界の便秘治療市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の便秘治療市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 便秘治療市場の競合情勢
  • 便秘治療市場企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson
    • AbbVie Inc.
    • Bayer AG
    • Novartis AG

第31章 その他の大手および革新的な企業

  • Merck &Co. Inc.
  • Sanofi SA
  • AstraZeneca plc
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Ltd.
  • Boehringer Ingelheim International GmbH
  • Regeneron Pharmaceuticals
  • Bausch Health Companies Inc.
  • Eisai Co. Ltd.
  • Shionogi &Co. Ltd.
  • Mallinckrodt Plc
  • Salix Pharmaceuticals Inc.
  • Prestige Consumer Healthcare Inc.
  • Taiho Pharmaceutical Co. Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13609

Constipation treatment encompasses various methods and strategies aimed at alleviating and managing the condition, characterized by irregular or challenging bowel movements, often resulting in hard or dry stools. These treatments aim to address symptoms and promote regularity in bowel function.

The primary therapeutic approaches for treating constipation include various categories such as laxatives, chloride channel activators, peripherally acting mu-opioid receptor antagonists, GC-C (guanylate cyclase-c) agonists, and other related remedies. Laxatives, for instance, facilitate the passage of stool in the intestines, aiding in constipation treatment by enhancing stool size, frequency, and motility. They are commonly utilized in managing chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and opioid-induced constipation (OIC). These treatments are made available through multiple distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacy platforms.

The constipation treatment market research report is one of a series of new reports from The Business Research Company that provides constipation treatment market statistics, including constipation treatment industry global market size, regional shares, competitors with a constipation treatment market share, detailed constipation treatment market segments, market trends and opportunities, and any further data you may need to thrive in the constipation treatment industry. This constipation treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The constipation treatment market size has grown strongly in recent years. It will grow from $10.95 billion in 2023 to $11.65 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The observed growth in the historic period can be attributed to several factors. These include the increasing prevalence of digestive disorders among the population, demographic shifts impacting health patterns, lifestyle factors influencing digestive health, limited availability of effective treatment options for constipation, and a growing awareness among individuals about health-related issues, including digestive disorders.

The constipation treatment market size is expected to see strong growth in the next few years. It will grow to $15.09 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. Anticipated growth in the forecast period can be attributed to several key factors. These include an increase in healthcare expenditure globally, a heightened emphasis on preventive healthcare measures, a growing focus on addressing pediatric constipation concerns, an escalating demand for personalized healthcare solutions, the rising prominence of telemedicine services, the expansion of e-commerce platforms in the healthcare sector, and a notable interest in functional foods and probiotics for digestive health. Major trends expected during this period encompass advancements in healthcare technology, including the integration of artificial intelligence and machine learning, a greater emphasis on sustainability and the production of eco-friendly healthcare products, collaborations between healthcare providers and technology firms for innovative solutions, and increased research and development investments by pharmaceutical companies to advance constipation treatments and healthcare solutions.

The upward trend in the consumption of fast food is anticipated to drive the growth of the constipation treatment market. Fast food, characterized by its quick preparation and service, often lacks sufficient fiber and tends to be high in fat and salt, contributing to constipation-related issues. As reported in August 2023 by Budget Branders, a US-based provider of paper and plastic products, the global market value of the fast food industry is projected to reach $931.7 billion by 2027. The US alone boasts over 200,000 distinct fast-food outlets, with consumers annually spending a staggering $200 billion on fast food. This surge in fast-food consumption underlines the growing need for constipation treatment solutions.

The escalating incidence of gastrointestinal disorders is poised to propel the constipation treatment market's growth. Gastrointestinal disorders, encompassing a spectrum of conditions affecting the digestive tract, often manifest constipation as a prevalent symptom. The constipation treatment market stands to benefit from the rising prevalence of gastrointestinal disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). A May 2021 report by BioMed Central, a UK-based journal, highlights the significant anticipated increase in the prevalence of Inflammatory Bowel Disease (IBD) by 2035. Regions such as Iran, North Africa, the Middle East, India, East Asia, high-income Asia-Pacific, and Southeast Asia are expected to experience varying degrees of growth in IBD cases. This increasing prevalence of gastrointestinal disorders underscores the demand for effective constipation treatment options, emphasizing the market's growth trajectory.

Product innovation emerges as a pivotal trend gaining traction in the constipation treatment market. Companies operating in this market are strategically focusing on developing novel products to fortify their market position. A notable example is Ardelyx, a US-based biopharmaceutical company, which introduced IBSRELA in April 2022. IBSRELA represents a breakthrough treatment for irritable bowel syndrome with constipation (IBS-C) in adults, being the first-in-class therapy developed in over a decade. This innovative medication addresses symptoms such as constipation, bloating, and stomach pain, offering a substantial new treatment option for individuals affected by IBS-C.

Major players in the constipation treatment market are actively engaged in the development of groundbreaking products, including ready-to-drink suspensions, aiming to cater to a broader customer base, drive increased sales, and boost overall revenue. For instance, in October 2022, Navamedic ASA, a Norway-based pharmaceutical company, unveiled ForlaxGo. This unique product serves as a convenient solution for occasional constipation, providing on-the-go ease with its ready-to-drink suspension format. Tailored for adults and children over 8 years old, ForlaxGO features macrogol as its primary component, delivering a natural sense of relief. Its standout characteristic lies in the presentation as a pre-measured, single-dose sachet, offering a hassle-free, ready-to-use solution. Significantly, ForlaxGO is available over-the-counter at pharmacies, eliminating the need for a prescription. This strategic approach to product innovation underscores the commitment of major companies to meet evolving consumer needs in the constipation treatment market.

In March 2023, Ipsen, a pharmaceutical company headquartered in France, completed the acquisition of Albireo Pharma Inc. The specific financial details of this acquisition were not disclosed. Ipsen's strategic acquisition of Albireo Pharma Inc. signifies a move to enhance its portfolio within the realm of rare diseases. Albireo Pharma Inc., based in the United States, specializes in biotechnology and focuses on the development of medications targeting chronic constipation treatment. This acquisition is expected to strengthen Ipsen's presence and offerings in the field of rare disease therapeutics, particularly in addressing chronic constipation-related treatments and solutions.

Major companies operating in the constipation treatment market report are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Fresenius Kabi AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Ltd., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals, Bausch Health Companies Inc., Eisai Co. Ltd., Shionogi & Co. Ltd., Mallinckrodt PLC, Salix Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., Taiho Pharmaceutical Co. Ltd., Ironwood Pharmaceuticals Inc., Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, RedHill Biopharma Ltd., Probi AB, 4D Pharma plc

North America was the largest region in the constipation treatment market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the constipation treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The constipation treatment market consists of sales of polyethylene glycol, bisacodyl, tegaserod, lubiprostone, and senna. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Constipation Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on constipation treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for constipation treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The constipation treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Therapeutic Types: Laxatives; Chloride Channel Activators; Peripherally Acting Mu-Opioid Receptor Antagonists; GC-C (Guanylate Cyclase-C) Agonists; Other Therapeutics
  • 2) By Disease Type: Chronic Idiopathic Constipation (CIC); Irritable Bowel Syndrome With Constipation (IBS-C); Opioid-Induced Constipation (OIC)
  • 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Constipation Treatment Market Characteristics

3. Constipation Treatment Market Trends And Strategies

4. Constipation Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Constipation Treatment Market Size and Growth

  • 5.1. Global Constipation Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Constipation Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Constipation Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Constipation Treatment Market Segmentation

  • 6.1. Global Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Laxatives
  • Chloride Channel Activators
  • Peripherally Acting Mu-Opioid Receptor Antagonists
  • GC-C (Guanylate Cyclase-C) Agonists
  • Other Therapeutics
  • 6.2. Global Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chronic Idiopathic Constipation (CIC)
  • Irritable Bowel Syndrome With Constipation (IBS-C)
  • Opioid-Induced Constipation (OIC)
  • 6.3. Global Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

7. Constipation Treatment Market Regional And Country Analysis

  • 7.1. Global Constipation Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Constipation Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Constipation Treatment Market

  • 8.1. Asia-Pacific Constipation Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Constipation Treatment Market

  • 9.1. China Constipation Treatment Market Overview
  • 9.2. China Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Constipation Treatment Market

  • 10.1. India Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Constipation Treatment Market

  • 11.1. Japan Constipation Treatment Market Overview
  • 11.2. Japan Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Constipation Treatment Market

  • 12.1. Australia Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Constipation Treatment Market

  • 13.1. Indonesia Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Constipation Treatment Market

  • 14.1. South Korea Constipation Treatment Market Overview
  • 14.2. South Korea Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Constipation Treatment Market

  • 15.1. Western Europe Constipation Treatment Market Overview
  • 15.2. Western Europe Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Constipation Treatment Market

  • 16.1. UK Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Constipation Treatment Market

  • 17.1. Germany Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Constipation Treatment Market

  • 18.1. France Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Constipation Treatment Market

  • 19.1. Italy Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Constipation Treatment Market

  • 20.1. Spain Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Constipation Treatment Market

  • 21.1. Eastern Europe Constipation Treatment Market Overview
  • 21.2. Eastern Europe Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Constipation Treatment Market

  • 22.1. Russia Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Constipation Treatment Market

  • 23.1. North America Constipation Treatment Market Overview
  • 23.2. North America Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Constipation Treatment Market

  • 24.1. USA Constipation Treatment Market Overview
  • 24.2. USA Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Constipation Treatment Market

  • 25.1. Canada Constipation Treatment Market Overview
  • 25.2. Canada Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Constipation Treatment Market

  • 26.1. South America Constipation Treatment Market Overview
  • 26.2. South America Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Constipation Treatment Market

  • 27.1. Brazil Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Constipation Treatment Market

  • 28.1. Middle East Constipation Treatment Market Overview
  • 28.2. Middle East Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Constipation Treatment Market

  • 29.1. Africa Constipation Treatment Market Overview
  • 29.2. Africa Constipation Treatment Market, Segmentation By Therapeutic Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Constipation Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Constipation Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Constipation Treatment Market Competitive Landscape
  • 30.2. Constipation Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AbbVie Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Constipation Treatment Market Other Major And Innovative Companies

  • 31.1. Merck & Co. Inc.
  • 31.2. Sanofi S.A.
  • 31.3. AstraZeneca plc
  • 31.4. Fresenius Kabi AG
  • 31.5. GlaxoSmithKline plc
  • 31.6. Takeda Pharmaceutical Company Ltd.
  • 31.7. Boehringer Ingelheim International GmbH
  • 31.8. Regeneron Pharmaceuticals
  • 31.9. Bausch Health Companies Inc.
  • 31.10. Eisai Co. Ltd.
  • 31.11. Shionogi & Co. Ltd.
  • 31.12. Mallinckrodt Plc
  • 31.13. Salix Pharmaceuticals Inc.
  • 31.14. Prestige Consumer Healthcare Inc.
  • 31.15. Taiho Pharmaceutical Co. Ltd.

32. Global Constipation Treatment Market Competitive Benchmarking

33. Global Constipation Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Constipation Treatment Market

35. Constipation Treatment Market Future Outlook and Potential Analysis

  • 35.1 Constipation Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Constipation Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Constipation Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer